Used Is the New "New" - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Used Is the New "New"
Used packaging equipment can be a cost-saving, time-saving alternative to new machines.


Pharmaceutical Technology
pp. 42-46

Preparing equipment

Like Frain, AEK Packaging and Loeb Equipment dedicate a substantial amount of floor space to refurbishing. These dealers employ engineers and technicians who prepare the equipment for delivery and recondition it as necessary.


Looking a bit like a trade show, the warehouse floor at Loeb Equipment displays used packaging machines and entire packaging lines for prospective buyers' inspection. (IMAGE IS COURTESY OF LOEB EQUIPMENT)
Equipment preparation varies, but typically involves a thorough cleaning; confirmation that mechanical, electrical, and computer systems are in good working order; and replacement of wear parts, which often are sourced from the original equipment manufacturer. If necessary, controls are upgraded and change parts crafted. In fact, "We have developed a global network of suppliers for controls and change parts," reports Christensen.

Value-added services

Machines typically are supplied with complete documentation, including manuals and schematic drawings. Transactions also may include guarantees, warranties, and right-of-return agreements.

Some dealers provide acceptance testing, setup, and training. Line integration and aftermarket service also can be part of the vendor's package. However, postsale service typically requires a separate service agreement.

Deciding how to pay for a machine can involve almost as much thought as determining exactly which machine to buy. Options include cash payment, leasing, and renting. Each choice presents a different degree of flexibility. Likewise, each has advantages and disadvantages.


Many used packaging machines such as this Pharmacarton Coding System from Nutec Systems (Lawrenceville, NJ) have not seen extensive operation. (PHOTO IS COURTESY OF AARON COMPANIES)
Cash payment results in full ownership, but it represents a capital expenditure and requires a capital budget. In most cases, accounting personnel must track depreciation for several years after the purchase.

Leasing, either directly through the dealer or through a third-party company, spreads payments out during a specific term. At the end of the term, the equipment is returned or purchased for a price that reflects the lease payments.

Renting does not require a commitment of more than a month or two, therefore it provides the most flexibility. In addition, rental fees are considered as expenses, so equipment can be purchased without touching the capital budget. Thus, renting is particularly well-suited to addressing seasonal spikes in demand, product introductions, and contract packaging situations.

"Renting makes it possible to put a product on the market very fast and very economically," explains Christensen, noting that it also "provides the opportunity to test a machine before you commit." If the new product is not successful, the equipment can simply be returned. If the product succeeds, the rental can become a purchase. In that case, "we apply part of the rental [fees] to the purchase price," says Madden of Frain.

Managing surplus assets

Dealers that sell used packaging equipment are always looking to buy late-model systems that have been properly maintained. "We're probably offered 50 machines per day, but only pursue five to 10," says Christensen.

In addition to purchasing surplus assets directly, many dealers also offer asset-redeployment services. Frain, for example, consolidates and manages surplus assets using a three-tier process that includes purchasing assets for cash, marketing them on a consignment basis, and purchasing assets for credit toward a machine or service.

Hallie Forcinio is Pharmaceutical Technology's Packaging Forum editor, 4708 Morningside Drive, Cleveland, OH 44109, tel. 216.351.5824, fax 216.351.5684,


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
27%
Oversee medical treatment of patients in the US.
14%
Provide treatment for patients globally.
8%
All of the above.
41%
No government involvement in patient treatment or drug development.
11%
Jim Miller Outsourcing Outlook Jim MillerCMO Industry Thins Out
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerFluorination Remains Key Challenge in API Synthesis
Marilyn E. Morris Guest EditorialMarilyn E. MorrisBolstering Graduate Education and Research Programs
Jill Wechsler Regulatory Watch Jill Wechsler Biopharma Manufacturers Respond to Ebola Crisis
Sean Milmo European Regulatory WatchSean MilmoHarmonizing Marketing Approval of Generic Drugs in Europe
FDA Reorganization to Promote Drug Quality
FDA Readies Quality Metrics Measures
New FDA Team to Spur Modern Drug Manufacturing
From Generics to Supergenerics
CMOs and the Track-and-Trace Race: Are You Engaged Yet?
Source: Pharmaceutical Technology,
Click here